Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections.
Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. Int J Antimicrob Agents. 2020 Dec; 56(6):106210.